share / bookmark page
EIF'S National Colorectal Cancer Research Alliance
Colorectal cancer is the second leading cause of cancer-related deaths in America. Yet, this cancer is largely preventable through appropriate screening and can be cured 90% of the time when detected early. EIF’s NCCRA is leading the national effort to raise awareness for the importance of getting screened and has awarded millions of dollars in grants to improve the way colon cancer is prevented, detected and treated.
Raising Awareness To Get People Screened Highlighting Public Policy
Where does the money go?
EIF’s NCCRA funding supports cutting-edge research at several leading institutions conducted by world-class scientists working on prevention, diagnostic tools, treatment, and, ultimately, a cure for colorectal cancer:
Dennis J. Slamon, M.D., Ph.D
Jonsson Comprehensive Cancer Center
David Geffen School of Medicine at UCLA
NCCRA Chair
With EIF seed funding, Dr. Dennis Slamon’s research at the Jonsson Cancer Center at UCLA focused on studying specific genetic alterations associated with the development and progression of colorectal cancer. By focusing on a specific area of the chromosome associated with colon cancer, called 20-q, Dr. Slamon and his team have identified ten possible candidate ...
Learn More